Products

Yourtale

AI-native

The questions nobody ever asked your mother or father.

yourtale.art Writing & Documents / Books & Self-Publishing

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$199/mo
Higher than 96% of peersNiche median $15/mo
Creators
Unlinked
No verified creators
Launched
18mo ago
2025-05-15 · Est.

Traffic

Monthly visitsData through Oct 2026

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Uneed (#8)Launch

    Yourtale

    May 15, 2025 · 18mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2025-01-11

KeywordMonthly volume
best life story book services470
profesional interview for posterity380
storyworth vs remento0

Traffic data: Vaneform

Pricing

Book
$199/once

Trial: None · 1 paid tier ($199) · Observed 2026-11-04 · Source page

Entry price $199/mo, Higher than 96% of peers; “Books & Self-Publishing” median is $15/mo.View pricing benchmark

Pages & changes

Tracked since 2026-08-09

Key pages

Weekly snapshots
Home
www.yourtale.art/en Snapshot 2026-11-04

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much does Yourtale cost?
Book: $199/once. Observed 2026-11-04. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does Yourtale get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Yourtale and what platforms does it support?
Yourtale is catalogued under Books & Self-Publishing: The questions nobody ever asked your mother or father. Supported platforms: Web.

Related products in this category

Writing & Documents / Books & Self-Publishing

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.